JP2012508027A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2012508027A5 JP2012508027A5 JP2011535765A JP2011535765A JP2012508027A5 JP 2012508027 A5 JP2012508027 A5 JP 2012508027A5 JP 2011535765 A JP2011535765 A JP 2011535765A JP 2011535765 A JP2011535765 A JP 2011535765A JP 2012508027 A5 JP2012508027 A5 JP 2012508027A5
- Authority
- JP
- Japan
- Prior art keywords
- cadherin
- seq
- diabody
- cells
- antibody
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US11304208P | 2008-11-10 | 2008-11-10 | |
| US61/113,042 | 2008-11-10 | ||
| PCT/US2009/063881 WO2010054377A2 (en) | 2008-11-10 | 2009-11-10 | Fully human antibodies against n-cadherin |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2012508027A JP2012508027A (ja) | 2012-04-05 |
| JP2012508027A5 true JP2012508027A5 (https=) | 2012-12-20 |
Family
ID=42153647
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2011535765A Pending JP2012508027A (ja) | 2008-11-10 | 2009-11-10 | Ｎ−カドヘリンに対する完全ヒト抗体 |
Country Status (13)
| Country | Link |
|---|---|
| US (2) | US8703920B2 (https=) |
| EP (1) | EP2356145A4 (https=) |
| JP (1) | JP2012508027A (https=) |
| KR (1) | KR20110084309A (https=) |
| CN (1) | CN102300873A (https=) |
| AU (1) | AU2009313239A1 (https=) |
| BR (1) | BRPI0921457A2 (https=) |
| CA (1) | CA2743122A1 (https=) |
| CO (1) | CO6362022A2 (https=) |
| IL (1) | IL212795A0 (https=) |
| MX (1) | MX2011004945A (https=) |
| RU (1) | RU2011123655A (https=) |
| WO (1) | WO2010054377A2 (https=) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8663635B2 (en) | 2006-03-21 | 2014-03-04 | The Regents Of The University Of California | N-cadherin: target for cancer diagnosis and therapy |
| WO2007109347A2 (en) * | 2006-03-21 | 2007-09-27 | The Regents Of The University Of California | N-cadherin and ly6 e: targets for cancer diagnosis and therapy |
| JP2011521619A (ja) * | 2008-04-04 | 2011-07-28 | ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア | 腫瘍成長、血管新生および転移を妨害する癌標的に対する新規抗体 |
| US8703920B2 (en) | 2008-11-10 | 2014-04-22 | The Regents Of The University Of California | Fully human antibodies against N-cadherin |
| GB201119089D0 (en) | 2011-11-04 | 2011-12-21 | Isis Innovation | Treatment of musculoskeletal fibroproliferative disorders |
| EP2830659A1 (en) | 2012-03-27 | 2015-02-04 | Novartis AG | Treatment of fibrosis |
| WO2016028663A1 (en) * | 2014-08-21 | 2016-02-25 | Johnson Controls Technology Company | Battery monitoring system |
| US20200165351A1 (en) * | 2017-06-06 | 2020-05-28 | The Regents Of The University Of California | Humanized anti-n-cadherin antibodies and uses thereof |
| CN117295770A (zh) * | 2021-05-13 | 2023-12-26 | 上海药明生物技术有限公司 | 包含抗p-钙粘蛋白抗体的抗体缀合物及其用途 |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5889157A (en) * | 1990-10-12 | 1999-03-30 | The United States Of America As Represented By The Department Of Health And Human Services | Humanized B3 antibody fragments, fusion proteins, and uses thereof |
| AU669124B2 (en) * | 1991-09-18 | 1996-05-30 | Kyowa Hakko Kirin Co., Ltd. | Process for producing humanized chimera antibody |
| US6680175B2 (en) * | 1998-05-05 | 2004-01-20 | Adherex Technologies, Inc. | Methods for diagnosing and evaluating cancer |
| US6277824B1 (en) * | 1998-07-10 | 2001-08-21 | Adherex Technologies | Compounds and methods for modulating adhesion molecule function |
| AU2001249064A1 (en) | 2000-02-22 | 2001-09-03 | Mount Sinai School Of Medicine Of New York University | N-cadherin modulated migration, invasion, and metastasis |
| US20030190602A1 (en) * | 2001-03-12 | 2003-10-09 | Monogen, Inc. | Cell-based detection and differentiation of disease states |
| SI1629011T1 (sl) * | 2003-05-31 | 2010-05-31 | Micromet Ag | Humane molekule za vezavo anti hu cd |
| US7973139B2 (en) * | 2004-03-26 | 2011-07-05 | Human Genome Sciences, Inc. | Antibodies against nogo receptor |
| EP1907858A4 (en) * | 2005-06-13 | 2009-04-08 | Univ Michigan | COMPOSITIONS AND METHODS OF TREATMENT AND DIAGNOSIS OF CANCER |
| US8663635B2 (en) * | 2006-03-21 | 2014-03-04 | The Regents Of The University Of California | N-cadherin: target for cancer diagnosis and therapy |
| US20100278821A1 (en) * | 2006-03-21 | 2010-11-04 | The Regents Of The University Of California | N-cadherin: target for cancer diagnosis and therapy |
| WO2007109347A2 (en) | 2006-03-21 | 2007-09-27 | The Regents Of The University Of California | N-cadherin and ly6 e: targets for cancer diagnosis and therapy |
| JP2011521619A (ja) | 2008-04-04 | 2011-07-28 | ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア | 腫瘍成長、血管新生および転移を妨害する癌標的に対する新規抗体 |
| US8703920B2 (en) | 2008-11-10 | 2014-04-22 | The Regents Of The University Of California | Fully human antibodies against N-cadherin |
-
2009
- 2009-11-09 US US12/590,601 patent/US8703920B2/en not_active Expired - Fee Related
- 2009-11-10 RU RU2011123655/10A patent/RU2011123655A/ru unknown
- 2009-11-10 CN CN2009801544698A patent/CN102300873A/zh active Pending
- 2009-11-10 EP EP09825592A patent/EP2356145A4/en not_active Withdrawn
- 2009-11-10 MX MX2011004945A patent/MX2011004945A/es unknown
- 2009-11-10 JP JP2011535765A patent/JP2012508027A/ja active Pending
- 2009-11-10 BR BRPI0921457A patent/BRPI0921457A2/pt not_active Application Discontinuation
- 2009-11-10 KR KR1020117013339A patent/KR20110084309A/ko not_active Withdrawn
- 2009-11-10 AU AU2009313239A patent/AU2009313239A1/en not_active Abandoned
- 2009-11-10 WO PCT/US2009/063881 patent/WO2010054377A2/en not_active Ceased
- 2009-11-10 CA CA2743122A patent/CA2743122A1/en not_active Abandoned
-
2011
- 2011-05-09 IL IL212795A patent/IL212795A0/en unknown
- 2011-06-08 CO CO11070983A patent/CO6362022A2/es not_active Application Discontinuation
-
2013
- 2013-06-17 US US13/919,652 patent/US20140017240A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2012508027A5 (https=) | ||
| CN110536900B (zh) | 调节补体依赖性细胞溶解效应子功能的修饰的人igm恒定区 | |
| CN105837688B (zh) | 单域抗体及其编码基因，免疫毒素及其编码基因、制备方法、表达载体、应用，及宿主细胞 | |
| JP2018503401A (ja) | 腫瘍壊死因子 （ｔｎｆ） スーパーファミリー受容体結合分子およびその使用 | |
| CN113480657B (zh) | 针对her2的单域抗体及其衍生蛋白和应用 | |
| RU2009118621A (ru) | Агонистические антитела против notch3 и их применение для лечения ntch3-ассоциированных заболеваний | |
| JP2003510366A (ja) | Ａｐｒｉｌレセプター（ｂｃｍａ）およびその使用 | |
| KR101671955B1 (ko) | 항 ＴＮＦ-α/ＣＸＣＬ10 이중 타겟 항체 및 그의 용도 | |
| CN109206514A (zh) | Tslp单克隆抗体及其制备方法和应用 | |
| TWI688575B (zh) | 阻礙血管內皮脂酶之酵素活性的人類化單株抗體 | |
| CN109705225B (zh) | 一种抗人caix抗原的嵌合抗原受体及其应用 | |
| CN111620951A (zh) | EGFP-Wnt2融合蛋白抗原和Wnt2单克隆抗体以及Wnt2单克隆抗体的应用 | |
| CN101293924A (zh) | 骨桥蛋白的功能表位、与其特异性结合的单克隆抗体及其在制备抗肿瘤转移药物中的用途 | |
| CN113321721B (zh) | 一种细胞外Ezrin蛋白及其应用 | |
| CA2323091A1 (en) | Nephrin gene and protein | |
| WO2011024114A1 (en) | Targeting extracellular matrix molecules for the treatment of cancer | |
| CN115058430A (zh) | 一种拟穴青蟹5-ht2受体基因及其应用 | |
| JP6574033B2 (ja) | Ｗｎｔ蛋白質の製造方法および保存方法 | |
| KR20100118900A (ko) | 사이토케라틴１７―특이적인 인간항체 | |
| CN101544695A (zh) | 人源化抗cd25单链抗体及制备方法 | |
| CN117866902A (zh) | 具有抗il-17a活性的基因修饰干细胞及其制备方法以及药物组合物 | |
| CN117866903A (zh) | 单域抗体修饰的干细胞及其在疾病治疗中用途 | |
| CN110117325B (zh) | 一种猪cd127多肽及其编码基因和应用 | |
| JP3288716B2 (ja) | ヒト接着分子オクルディン | |
| CN107686519A (zh) | 抗小鼠mxra7单克隆抗体的制备方法及其应用 |